STD, AIDS Risks Despite Today Sponge Use Conveyed In Labeling - NDAC
This article was originally published in The Tan Sheet
Executive Summary
Proposed labeling for Allendale Pharmaceuticals' Today Sponge contains adequate information regarding Toxic Shock Syndrome (TSS), STDs and AIDS, the Nonprescription Drugs Advisory Committee determined July 12.
You may also be interested in...
Today Sponge Sale To Americans By Internet Pharmacies Investigated By FDA
FDA is looking into online pharmacies' sale of the Today Sponge contraceptive to American consumers despite its lack of approval for sale in the U.S
Today Sponge Comparative Efficacy Labeling Supported By NDAC
FDA's Nonprescription Drugs Advisory Committee voted in favor of placing comparative efficacy labeling on the outer packaging of Allendale Pharmaceuticals' Today Sponge vaginal contraceptive at a July 12 meeting in Bethesda, Md.
Allendale Pharma Today Sponge Relaunch $3 Mil. PR/Ad Campaign Planned
The U.S. relaunch of the Today Sponge is on the horizon, with an FDA inspection of the manufacturing facility for the OTC nonoxynol-9 contraceptive slated for the week of May 22. The product's marketer, Allendale Pharmaceuticals, submitted a supplemental NDA Jan. 23.